Skip to content
OpenCapital
Get started

TriSalus Life Sciences, Inc. TLSI Cash ratio

Cash ratio at other companies

Boston Scientific logo
Boston ScientificBSX
0.2×+0.1×
AngioDynamics logo
AngioDynamicsANGO
0.6×0.0×
InfuSystem Holdings logo
InfuSystem HoldingsINFU
0.1×0.0×
Delcath Systems logo
Delcath SystemsDCTH
3.9×+1.4×
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
2.1×-0.3×
LQD
Liquidia CorporationLQDA
1.5×-1.3×

Other financials

Income statement

See full
Revenue$8.9M-2.9%
Gross profit$7.7M0.0%
Operating income-$8.4M-14.8%
Net income$1.5M+115%
EPS (diluted)$0.03+108%

Balance sheet

See full
Cash & equivalents$56.6M+324%
Total debt$33.1M+4.4%
Total equity$12.8M+137%
Total assets$71.0M+148%

Cash flow

See full
Operating cash flow-$6.5M-44.0%
CapEx$141.0K-81.3%
Free cash flow-$6.6M-26.0%

Valuation

See full
Market cap$279.45M+49.6%
Enterprise value$255.97M+33.6%
P/S6.2×+1.0×

Profitability

See full
Gross margin85.1%-0.5pp
Operating margin-62.4%-16.8pp
Net margin-60.9%-13.4pp
FCF margin-45.2%-16.8pp

Returns & leverage

See full
Return on equity253.3%—
Debt / equity2.6×—
Current ratio5.8×+3.6×

Where this comes from

Calculated from TriSalus Life Sciences, Inc.’s reported figures.

cash and equivalents/total current liabilities=4.8×

Based on the most recent quarter.

The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about TriSalus Life Sciences, Inc.'s cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TriSalus Life Sciences, Inc.'s cash ratio?
TriSalus Life Sciences, Inc. (TLSI) reported cash ratio of 4.8× in Q1 2026.
How has TriSalus Life Sciences, Inc.'s cash ratio changed year-over-year?
TriSalus Life Sciences, Inc.'s cash ratio increased by 322.4% year-over-year, from 1.1× to 4.8×.
What is the long-term trend for TriSalus Life Sciences, Inc.'s cash ratio?
Over 4 years (2021 to 2025), TriSalus Life Sciences, Inc.'s cash ratio has grown at a -44.4% compound annual growth rate (CAGR), from 18.9× to 1.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.